Aligos Therapeutics, Inc. (ALGS)
5.34
+0.03
(+0.56%)
USD |
NASDAQ |
Oct 09, 16:00
5.32
-0.02
(-0.37%)
After-Hours: 20:00
Aligos Therapeutics Profit Margin (Quarterly) : -5.41% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -5.41% |
| March 31, 2026 | -814.1% |
| December 31, 2025 | -11.76K% |
| September 30, 2025 | -4.26K% |
| June 30, 2025 | -1.64K% |
| March 31, 2025 | |
| December 31, 2024 | -13.06K% |
| September 30, 2024 | -1.52K% |
| June 30, 2024 | |
| March 31, 2024 | -3.54K% |
| December 31, 2023 | -1.04K% |
| Date | Value |
|---|---|
| September 30, 2023 | -557.0% |
| June 30, 2023 | -272.9% |
| March 31, 2023 | -843.0% |
| December 31, 2022 | -618.8% |
| September 30, 2022 | -453.5% |
| June 30, 2022 | -539.5% |
| March 31, 2022 | -1.39K% |
| December 31, 2021 | -10.28K% |
| September 30, 2021 | -2.16K% |
| June 30, 2021 | -1.93K% |
| March 31, 2021 | -3.04K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Agenus, Inc. | -1.64% |
| Amgen, Inc. | 23.59% |
| Anika Therapeutics, Inc. | 10.15% |
| BioCryst Pharmaceuticals, Inc. | 35.92% |
| Imunon, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -130.6% |
| Return on Assets | -81.69% |
| Return on Invested Capital | -119.8% |
| Gross Profit Margin (Quarterly) | 99.08% |
| Operating Margin (Quarterly) | -6.80% |
| Return on Net Operating Assets | -729.2% |